SAN DIEGO----ACADIA Pharmaceuticals Inc. , a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has been selected to be one of the inaugural companies in the new NASDAQ® NeuroInsights® Neurotech Index.
From: biz.yahoo.com
Tuesday, September 25, 2007
ACADIA Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
Posted by Ruslan Abuzant at 9:15 AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment